Living with Multiple Sclerosis: Spain's 55,000 patients navigate invisible illness

Fifty-five thousand people across Spain wake up each morning to a disease that refuses to announce itself. Multiple sclerosis is what doctors call a condition of a thousand faces—visible one moment, invisible the next, and almost always misunderstood by everyone watching from the outside.

N. Carmona learned this the hard way. Three years ago, she was a marathon runner. Then came the knee pain that wouldn't quit, the kind that sent her to an orthopedist for injections, the kind that seemed like a simple injury gone wrong. It wasn't. Her primary care doctor delivered the diagnosis that rewrote her life: a central nervous system disorder, multiple sclerosis, arriving when she was forty-four years old. The woman she had been—efficient, productive, defined by her job in human resources—suddenly had to negotiate with someone else living inside her body.

"In those first months, there was so much more of the disease than there was of me," she says now. The turning point came gradually. She stopped surrendering every hour to the illness. She still meets friends for drinks. She still laughs. Two years after diagnosis, she is planning her return to work, though the woman going back is not the same one who left. "If someone asks me who I am now, I tell them: myself," she says with quiet firmness. "I learned to stop and see life differently." The productivity metrics that once defined her no longer do.

But the disease has taught her something harder than acceptance: how to live in the space between visibility and invisibility. On the metro, fatigue sometimes makes standing unbearable, but she stays on her feet rather than ask for a seat, afraid of being judged by strangers who see a healthy-looking woman. When she does ask, the pendulum swings the other way—sudden, suffocating pity. There is no middle ground. "It's very difficult to make people understand that when you say you're tired, it's not because you feel like it," she explains. The disease doesn't announce itself. Neither does the exhaustion.

Multiple sclerosis strikes hardest at women. For every man diagnosed, three women receive the same news. It typically arrives in the prime of life, between ages twenty-five and thirty-five, when people are building careers, starting families, making plans that suddenly require revision. The disease can steal speech, impose relentless pain, drain energy to the point of immobility, fog the mind, trigger depression, unleash anxiety. The future becomes genuinely unknowable.

In Catalonia, the Multiple Sclerosis Foundation has recognized that women face a compounded vulnerability—not just from the disease itself, but from the economic precarity that often accompanies it, from the expectation that they will somehow continue to manage household care even as their bodies betray them, from the simple fact of having decades of life still ahead to navigate. The foundation launched a program called EmpoderEM, funded by La Caixa, designed to move beyond sympathy and toward genuine tools: psychological support, social resources, pedagogical frameworks that let women make their own decisions about how to live with the illness.

Sonia Mayó, who oversees the program, has watched something remarkable happen in the support groups. Women recognize themselves in each other's struggles. They begin organizing their own activities, arranging their own gatherings, asking the foundation only for information and space. Peer recognition becomes its own form of medicine. "They see themselves in each other; they meet up, they organize things on their own, and they only ask us for information or to provide the spaces," Mayó says.

There is no cure yet. But research is moving forward. Artificial intelligence is being tested to predict how the disease will progress in individual patients, which could allow doctors to tailor treatments more precisely rather than relying on one-size-fits-all protocols. The foundation has established reference centers across every province in Catalonia, recognizing that a disease affecting mobility demands that care be accessible, not concentrated in distant cities. The work is slow, unglamorous, and essential. Fifty-five thousand people are waiting to see what comes next.